💊 Semaglutide (Ozempic)
Ozempic (semaglutide) is a once-weekly subcutaneous injection and a GLP-1 receptor agonist. It is used in adults with type 2 diabetes to improve blood sugar control and, in specific groups, to reduce the risk of certain heart and kidney complications. It is available by prescription only.
In Arabic: سيماجلوتايد (أوزيمبيك)✅ What it is used for
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack, non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
- To reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
🧪 Active ingredient
The active ingredient is semaglutide, a GLP-1 analogue that binds to and activates the GLP-1 receptor. It stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, and slightly delays gastric emptying after meals.
🌿 Benefits
- Lowers fasting and after-meal blood glucose
- Reduces body weight (as described in the label's pharmacodynamics)
- Reduces the risk of major cardiovascular events in eligible patients
- Reduces the risk of kidney function decline in patients with type 2 diabetes and chronic kidney disease
📝 How to use
- Your dose is set by your doctor or pharmacist based on your condition; do not change it on your own
- Inject under the skin of the abdomen, thigh, or upper arm once weekly on the same day each week, at any time of day, with or without meals
- Use a different injection site each week when injecting in the same body region
- Inspect before use: it should be clear and colorless; do not use if particles or discoloration are seen
- When used with insulin, give as separate injections and never mix them; they may be injected in the same body region but not next to each other
- Never share a pen with another person, even if the needle is changed
💊 Dosage forms
- Single-patient-use pens with multiple weekly doses (2 mg/3 mL, 4 mg/3 mL, 8 mg/3 mL)
- Single-dose prefilled syringes (0.25 mg, 0.5 mg, or 1 mg per 0.5 mL)
⚠️ Common side effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Constipation
🚨 Serious — seek medical help
- Thyroid C-cell tumors (boxed warning: seen in rodents; human relevance unknown); symptoms include a neck mass, difficulty swallowing, shortness of breath, or persistent hoarseness
- Acute pancreatitis
- Diabetic retinopathy complications
- Severe hypoglycemia when used with insulin or sulfonylureas
- Acute kidney injury due to volume depletion
- Severe gastrointestinal reactions
- Serious hypersensitivity reactions (anaphylaxis, angioedema)
- Acute gallbladder disease (gallstones or cholecystitis)
- Pulmonary aspiration during general anesthesia or deep sedation
⛔ Do not use if
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Serious hypersensitivity reaction to semaglutide or any ingredient in the product
❗ Warnings & precautions
- Stop and seek medical advice promptly if pancreatitis or a serious allergic reaction is suspected
- Patients with a history of diabetic retinopathy should be monitored
- Not recommended in patients with severe gastroparesis
- Monitor kidney function in patients with reactions that could lead to volume depletion, such as vomiting or diarrhea
- If gallstones or gallbladder inflammation is suspected, gallbladder studies are indicated
- Tell your healthcare provider about any planned surgery or procedure involving anesthesia or deep sedation
- The dose of insulin or sulfonylureas may need to be reduced to lower the risk of low blood sugar
🔄 Drug interactions
- Insulin or sulfonylureas: increased risk of hypoglycemia, including severe hypoglycemia; consider reducing their dose when starting
- Oral medications: Ozempic delays gastric emptying and may affect absorption; it did not affect absorption to a clinically relevant degree in studies, but use caution with concomitant oral medications
🤰 Pregnancy
Data in pregnant women are limited, and animal studies suggest potential risk to the fetus. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. It should be discontinued at least 2 months before a planned pregnancy because of its long washout period. Talk to your doctor before planning pregnancy.
🍼 Breastfeeding
The label text provided does not include information on use during breastfeeding. Consult your doctor before using it.
🧒 Children
Safety and efficacy of Ozempic have not been established in pediatric patients.
👴 Older adults
No overall differences in safety or efficacy were detected between older and younger patients, but greater sensitivity in some older individuals cannot be ruled out.
🌡️ Storage
Storage conditions are not included in the label text provided. Follow the instructions in the package leaflet and your pharmacist's advice.
⏰ Missed dose
If a dose is missed, inject it as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and take the next dose on the regularly scheduled day, then resume the usual weekly schedule. The day of weekly dosing can be changed if at least 2 days (>48 hours) separate two doses.
🆘 Overdose
In case of overdose, supportive treatment is given according to symptoms. Contact a poison control center or seek emergency care immediately. A prolonged period of observation and treatment may be needed because the drug's half-life is approximately 1 week.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| OZEMPIC 0.25MG/0.19ML - PFP SEMAGLUTIDE 1.34MG/ML | MSS | 1 PFP | 388 ₪ |
| OZEMPIC 0.5MG/0.37ML - PFP SEMAGLUTIDE 1.34MG/ML | MSS | 1 PFP | 388 ₪ |
| OZEMPIC 1MG/0.74ML - PFP SEMAGLUTIDE 1.34MG/ML | MSS | 1 PFP | 401 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
GLP-1 receptor agonist with 94% sequence homology to human GLP-1. Stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, with a minor delay in early postprandial gastric emptying. Albumin binding reduces renal clearance and protects against metabolic degradation, giving a long half-life; it is also stabilized against DPP-4. The mechanism of kidney-related risk reduction has not been established.
Labeled dosing
Adults: initiate at 0.25 mg subcutaneously once weekly for 4 weeks, then 0.5 mg once weekly. If additional glycemic control is needed, increase to 1 mg after at least 4 weeks on 0.5 mg, then to 2 mg after at least 4 weeks on 1 mg. Maximum recommended dose is 2 mg once weekly. In type 2 diabetes with chronic kidney disease, increase to the 1 mg maintenance dose after at least 4 weeks on 0.5 mg. The final dose is determined by the prescriber.
- Boxed warning: risk of thyroid C-cell tumors; contraindicated in MTC and MEN 2; routine calcitonin monitoring or thyroid ultrasound is of uncertain value
- Dose escalation reduces the risk of gastrointestinal adverse reactions
- Consider reducing insulin or sulfonylurea dose when initiating to reduce hypoglycemia risk
- Monitor renal function in patients with reactions that could cause volume depletion
- Discontinue if pancreatitis or hypersensitivity is suspected
- Discontinue at least 2 months before a planned pregnancy
🎓 Key points for students
- GLP-1 receptor agonist given as a once-weekly subcutaneous injection
- Mechanism: glucose-dependent increase in insulin and decrease in glucagon, with a minor delay in gastric emptying
- Key warning (boxed): risk of thyroid C-cell tumors; contraindicated in MTC and MEN 2
- Most common adverse reactions (≥5%): nausea, vomiting, diarrhea, abdominal pain, constipation
- Long half-life (about 1 week) explains the weekly schedule and prolonged observation after overdose
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is Ozempic used for?
In adults with type 2 diabetes it is used to improve blood sugar control alongside diet and exercise, and in specific groups to reduce the risk of heart and kidney complications, as decided by the doctor.
How often is it injected?
Once weekly on the same day each week, at any time of day with or without meals. The dose is set by your doctor or pharmacist.
What should I do if I miss a dose?
Inject it as soon as possible within 5 days of the missed dose. If more than 5 days have passed, skip it and take the next dose on your regular day.
What are the most common side effects?
Nausea, vomiting, diarrhea, abdominal pain, and constipation. Seek medical help right away for severe abdominal pain, allergic symptoms, or a lump in the neck.
Who should not use it?
People with a personal or family history of medullary thyroid carcinoma, those with MEN 2, or those with a serious allergy to semaglutide or any of its ingredients.
Can it be used with insulin?
Yes, but as separate injections that are never mixed. Your insulin dose may need to be reduced to avoid low blood sugar, as decided by your doctor.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-07), simplified. Updated: 2026-11-15.